IRON Bathophenanthrolin(BIOLABO IRON Bathophenanthrolin)
- UID
- IMP/IVD/2023/000051_ff5621e678d89e156ccad35dc79b9adf_0ea18fc26fbfe6b272ccf7214aaf9cd4
- Device class
- Class B
- Brand name
- BIOLABO ACID CALCIUM Arsenazo III Method
- License holder
- Wheecon Instruments Private Limited
- Approving authority
- CDSCO
- Product information
- Serum iron concentration connotes the Fe3+ bound to the serum transferrin and does not include the iron contained in serum as free hemoglobin. Serum iron concentration is decreased in many but not all patients with iron deficiency anemia and in chronic inflammatory disorders such as infection, immunization, and myocardial infarction. Greater than normal concentrations of serum iron occur in iron loading disorders such as hemochromatosis, in acute iron poisoning in children, and after oral ingestion of iron medication or parenteral iron administration or acute hepatitis
IRON Bathophenanthrolin(BIOLABO IRON Bathophenanthrolin) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000051_ff5621e678d89e156ccad35dc79b9adf_0ea18fc26fbfe6b272ccf7214aaf9cd4. This device is marketed under the brand name BIOLABO ACID CALCIUM Arsenazo III Method. The license holder is Wheecon Instruments Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.